Compared with the standard-dose influenza vaccine, a high-dose quadrivalent inactivated influenza vaccine, GC3114, may provide a more effective influenza vaccine option for the elderly population.
In conjunction with its release of the adult guidelines earlier this year, the ACIP earlier this year has issued an annual update on pediatric immunization schedules.
Patients with diabetes are at higher risk for hospitalization and mortality because of pneumococcal infection; however, uptake of vaccination remains suboptimal.
In children aged 6–35 months, vaccination with 2 doses of IIV4 can protect against influenza and reduces the frequency of severe outcomes.
Postvaccination antibody titers against influenza A similar across successive vaccinations but efficacy wanes with vaccine rates.
A new vaccine candidate may stave off active TB in M tuberculosis-infected adults.
Among children there was an increased risk for acute respiratory illness caused by noninfluenza respiratory pathogens following influenza vaccination compared to unvaccinated children during the same period.
Influenza vaccination in the pediatric emergency department setting appears to be a cost-effective strategy.
Temporary discontinuation of methotrexate after influenza vaccination is associated with improved immunogenicity of vaccination in RA.
Low education and low income are linked to lower uptakes of PCV13 in minorities 65 years and older.
